Neoadjuvant chemoradiotherapy or chemotherapy followed by surgery is superior to that followed by definitive chemoradiation or radiotherapy in stage IIIA (N2) nonsmall-cell lung cancer: a meta-analysis and system review

BACKGROUND: Approximately 30% of all cases of nonsmall-cell lung cancer (NSCLC) are of a locally advanced (IIIA or IIIB) stage. However, surgical therapy for patients with stage IIIA (N2) NSCLC is associated with a disappointing 5-year survival rate. The optimal treatment for stage IIIA (N2) NSCLC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiao-Ling, Dan, Li, Chen, Wei, Zhu, Shuang-Mei, Mao, Wei-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768897/
https://www.ncbi.nlm.nih.gov/pubmed/26955282
http://dx.doi.org/10.2147/OTT.S95511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768897/
https://www.ncbi.nlm.nih.gov/pubmed/26955282
http://dx.doi.org/10.2147/OTT.S95511

Ejemplares similares